Diuretics versus others for long-term clinical outcomes as first-line antihypertensive medications: analysis of national real-world database

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Hypertension Research

• Publication date

  2022-03-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41440-022-00890-8PMID 35338336
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Korea hypertension fact sheet 2020: analysis of nationwide population-based data

  2021cited by this paper
• Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association

  2020cited by this paper
• Cardiovascular Research Using the Korean National Health Information Database

  2020cited by this paper
• Comparison of Cardiovascular Events Among Users of Different Classes of Antihypertension Medications

  2020cited by this paper
• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

  2019cited by this paper
• [2018 ESC/ESH Guidelines for the management of arterial hypertension].

  2019cited by this paper
• Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.

  2019influential reference
• 2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension

  2019cited by this paper
• Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

  2018cited by this paper
• 2018 ESC/ESH Guidelines for the management of arterial hypertension.

  2018cited by this paper
• Strengths and weaknesses of ‘real-world’ studies involving non-vitamin K antagonist oral anticoagulants

  2018cited by this paper
• 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2018cited by this paper
• Pharmacotherapy for hypertension in adults aged 18 to 59 years.

  2017cited by this paper
• An overview of meta-analysis for clinicians

  2017cited by this paper
• Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

  2017cited by this paper
• Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort

  2016influential reference
• Everolimus-eluting stents or bypass surgery for multivessel coronary disease.

  2015cited by this paper
• Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and β-adrenergic blockers? A systematic review

  2013cited by this paper
• ESH / ESC Guidelines for the management of arterial hypertension

  2013cited by this paper
• Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

  2009cited by this paper
• Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics.

  2008cited by this paper
• Race and Ethnicity in Trials of Antihypertensive Therapy to Prevent Cardiovascular Outcomes: A Systematic Review

  2007cited by this paper
• Role of Angiotensin II in Cardiovascular Disease — Therapeutic Implications of More Than a Century of Research

  2006cited by this paper
• Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines.

  2006cited by this paper
• Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

  2003cited by this paper
• Ethnicity and drug therapy for hypertension.

  2003cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2002cited by this paper
• Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension.

  2002cited by this paper
• Angiotensin II and trials of cardiovascular outcomes.

  2002cited by this paper
• Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

  2002cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

  1993cited by this paper
• Single-Drug Therapy for Hypertension in Men -- A Comparison of Six Antihypertensive Agents with Placebo

  1993cited by this paper
• Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study.

  1988cited by this paper
• Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial.

  1987cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Evaluation of the antihypertensive activity of the aqueous extract and the major flavonoid from Boldoa purpurascens Cav. leaves.

  2025cites this paper
• Preface–special issue on hypertension in Asia: the second story

  2022cites this paper
• Factors affecting the changes in antihypertensive medications in patients with hypertension

  2022cites this paper